A patient undergoing long-term hemodialysis for chronic kidney disease presents with intense pruritus, diffuse bone pain, and evidence of vascular calcifications. Which metabolic disturbance most likely accounts for these clinical features?
সমাধান
সঠিক উত্তর: Option A
In patients with chronic kidney disease (CKD), especially those on long-term hemodialysis, disturbances in mineral metabolism are common. The clinical presentation of intense pruritus, diffuse bone pain, and vascular calcifications is characteristic of a metabolic disorder related to altered calcium, phosphate, and parathyroid hormone (PTH) levels.
Secondary hyperparathyroidism is the most likely metabolic disturbance responsible for these features. This condition develops due to the kidneys' inability to excrete phosphate leading to hyperphosphatemia, and impaired synthesis of 1,25-dihydroxyvitamin D (active vitamin D). The lack of active vitamin D reduces calcium absorption from the gut, resulting in hypocalcemia. These changes stimulate the parathyroid glands to secrete excess PTH (secondary hyperparathyroidism) in an attempt to maintain calcium homeostasis.
Important pathophysiological points include:
- Elevated PTH levels cause increased bone resorption, leading to diffuse bone pain, renal osteodystrophy, and a risk of fractures.
- High phosphate and calcium levels promote vascular and soft tissue calcifications, contributing to morbidity by affecting cardiovascular health.
- Pruritus in CKD patients is often related to high phosphate levels and secondary hyperparathyroidism.
The other options are less consistent with the findings:
- Primary hypoparathyroidism would cause hypocalcemia without compensatory PTH elevation and is not typical in dialysis patients.
- Vitamin D intoxication leads to hypercalcemia and usually does not cause secondary hyperparathyroidism or pruritus.
- Hypophosphatemia due to malabsorption is not common in CKD and would not account for the vascular calcifications or the bone pain seen here.
Thus, the constellation of symptoms in a dialysis patient strongly indicates secondary hyperparathyroidism as the underlying metabolic disturbance.
Reference:
Brenner & Rector’s The Kidney, 10th Edition, Volume 2, Chapter 52 – Mineral and Bone Disorders in Chronic Kidney Disease, Page 1358-1365
Secondary hyperparathyroidism is the most likely metabolic disturbance responsible for these features. This condition develops due to the kidneys' inability to excrete phosphate leading to hyperphosphatemia, and impaired synthesis of 1,25-dihydroxyvitamin D (active vitamin D). The lack of active vitamin D reduces calcium absorption from the gut, resulting in hypocalcemia. These changes stimulate the parathyroid glands to secrete excess PTH (secondary hyperparathyroidism) in an attempt to maintain calcium homeostasis.
Important pathophysiological points include:
- Elevated PTH levels cause increased bone resorption, leading to diffuse bone pain, renal osteodystrophy, and a risk of fractures.
- High phosphate and calcium levels promote vascular and soft tissue calcifications, contributing to morbidity by affecting cardiovascular health.
- Pruritus in CKD patients is often related to high phosphate levels and secondary hyperparathyroidism.
The other options are less consistent with the findings:
- Primary hypoparathyroidism would cause hypocalcemia without compensatory PTH elevation and is not typical in dialysis patients.
- Vitamin D intoxication leads to hypercalcemia and usually does not cause secondary hyperparathyroidism or pruritus.
- Hypophosphatemia due to malabsorption is not common in CKD and would not account for the vascular calcifications or the bone pain seen here.
Thus, the constellation of symptoms in a dialysis patient strongly indicates secondary hyperparathyroidism as the underlying metabolic disturbance.
Reference:
Brenner & Rector’s The Kidney, 10th Edition, Volume 2, Chapter 52 – Mineral and Bone Disorders in Chronic Kidney Disease, Page 1358-1365